Congresul in oncologie ASCO 2015 - 29 mai- 2 iunie American Society of Clinical Oncology’s (ASCO) 51st Annual Meeting
Secțiunea: Tratament cancer in strainatate
2 comentarii
1
| 1 Violeta Astratinei |
30-05-2015, 03:13 |
|
Membru din 16-02-2015 Subiecte: 5 Comentarii: 11 |
Spre informare - stiri recente de la ASCO2015
ASCO 2015 , 29 May Terapiile imunologice noi de tip anti-PD1, cunoscute pentru melanoma, au aratat eficacitate si in cancerul de ficat, colorectal, endometrial, plaman, cap si gat. ''Recent data demonstrate effectiveness of immunotherapy drugs anti-PD1 not only in melanoma, but in advanced liver, head and neck, lung, and colorectal cancers...'' GENOMIC MARKER PREDICTS ANTI-PD-1 RESPONSE IN SEVERAL CANCERS NIVOLUMAB SHOWS HIGHLY PROMISING ACTIVITY IN ADVANCED LIVER CANCER IN EARLY-STAGE TRIAL PEMBROLIZUMAB SHOWS PROMISING ACTIVITY AGAINST HEAD AND NECK CANCER NIVOLUMAB EXTENDS SURVIVAL FOR PATIENTS WITH THE MOST COMMON LUNG CANCER Mai mult aici http://www.asco.org/press-center/new-immunotherapies-multiple-hard-treat-cancers Violeta Astratinei
Patient advocate in Melanoma Network Patient Europe http://www.melanomapatientnetworkeu.org/ Fondator comunitatea de pacienti Melanom Romania http://www.melanomromania.com https://www.facebook.com/melanomromania @MelanomRomania |
| 2 Violeta Astratinei |
30-05-2015, 03:20 |
|
Membru din 16-02-2015 Subiecte: 5 Comentarii: 11 |
ASCO 2015
La acest link se pot cauta rezumate ale cercetarilor pentru diferite cancere/arii de interes. http://abstracts.asco.org/156/CatView_156_S.html Violeta Astratinei
Patient advocate in Melanoma Network Patient Europe http://www.melanomapatientnetworkeu.org/ Fondator comunitatea de pacienti Melanom Romania http://www.melanomromania.com https://www.facebook.com/melanomromania @MelanomRomania |
2 comentarii
1
